Mustafa Ozgur Arici, Halil Goksel Guzel, Derya Kivrak Salim, Mustafa Karaca, Mustafa Yildiz, Banu Ozturk, Murat Kocer
Journal of Clinical Practice and Research - 2025;47(5):519-527
With more than 2 million new diagnoses and an estimated 1.8 million deaths by 2020, lung cancer (LC) remains a global health problem.1 Its incidence has declined as a result of effective anti-smoking policies implemented in recent decades.2 In addition, screening programs for individuals at risk have increased detection rates at earlier stages.3 However, survival from LC has improved only slightly, and when all stages are taken into account, the overall five-year prognosis is below 25%.4,5
